ANN ARBOR, Mich., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has signed a contract for the delivery of 2,000 mulberry trees. With the purchase of these trees, the Company will be able to significantly expand its US production of spider silk fibers including both Dragon Silk™ and Monster Silk®. The Company is currently preparing for the planting of these first two thousand trees and is actively assessing its requirements for additional trees.
Mulberry leaves are an important dietary requirement for the Company’s proprietary transgenic silkworms which spin recombinant spider silk. The planting of these trees is seen by the Company as the next step in expanding US production.
“The purchase of these trees is an important part of our plans to diversify our production both in the US and overseas. These trees will provide a sustainable, low cost, domestic input source for our US based silk production,” said COO Jon Rice. “In addition to decreasing our costs and ensuring a stable food supply for our transgenic silkworms, testing in the laboratory has demonstrated that our silkworms produce better silk when fed fresh mulberry.”
The Company plans to use its US based production operations as an agile responsive capacity for domestic orders and as a testbed for future market developments. This facility will work in parallel with the Company’s planned international high capacity operations.
To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.
For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc.